The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of minimal residual disease negativity (MRD-) with prognosis in high-risk myeloma (HRM).
 
Chutima Kunacheewa
No Relationships to Disclose
 
Krina K. Patel
No Relationships to Disclose
 
Hans Chulhee Lee
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Celgene; Pimera; Takeda
Research Funding - Amgen; Celgene; Daiichi Sankyo; Janssen; Prothena; Takeda
 
Sheeba K. Thomas
No Relationships to Disclose
 
Behrang Amini
No Relationships to Disclose
 
Samer Srour
No Relationships to Disclose
 
Qaiser Bashir
Consulting or Advisory Role - Amgen; Kite, a Gilead company; Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene; Takeda (Inst)
 
Muzaffar H. Qazilbash
Consulting or Advisory Role - Amgen
Speakers' Bureau - Merck; Sanofi
Research Funding - Amgen; Tesaro
 
Donna M. Weber
No Relationships to Disclose
 
Sattva Swarup Neelapu
Honoraria - Bio Ascend; Dava Oncology; Medscape; Physicans' Education Resource
Consulting or Advisory Role - Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics; poseida therapeutics; Unum Therapeutics
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; Dava Oncology; Kite/Gilead; Medscape; Merck; Novartis; Pfizer; Physicans' Education Resource; Precision Biosciences; Unum Therapeutics
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Takeda
Research Funding - Amgen; BioTheryX; Spectrum Pharmaceuticals
 
Lei Feng
No Relationships to Disclose
 
Pei Lin
No Relationships to Disclose
 
Elisabet Esteve Manasanch
Honoraria - Celgene; Novartis; Sanofi; Takeda
Research Funding - JW Pharmaceutical; Merck; Quest Diagnostics; Sanofi